Early revascularisation and 1-year survival in 14-day survivors of acute myocardial infarction: A prospective cohort study

Lancet

Volumn 359, Issue 9320, 2002, Pages 1805-1811

  Stenestrand, Ulf ^a   Wallentin, Lars ^b  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGRESSION ANALYSIS; SURVIVAL;

EID: 0037172391     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)08710-X     Document Type: Article

References (30)

1. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study
2. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial: A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction
3. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban
4. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy
5. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction
6. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction
7. Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI)
8. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: Results of the thrombolysis in myocardial infarction (TIMI) phase II trial
9. One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II Trial
10. Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction: Results of thrombolysis and angioplasty in myocardial infarction; Phase 5 randomized trial
11. SWIFT trial of delayed elective intervention v conservative treatment after thrombolysis with anistreplase in acute myocardial infarction
12. Thrombolysis with tissue plasminogen activator in acute myocardial infarction: No additional benefit from immediate percutaneous coronary angioplasty
13. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction
14. Effects of thrombolytic regimen, early catheterization, and predischarge angiographic variables on six-week left ventricular function
15. Variations between countries ininvasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation
16. The Organization to Assess Strategies for Ischemic Syndromes (OASIS) registry in patients with unstable angina
17. Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: Insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences
18. Early statin treatment following acute myocardial infarction and 1-year survival
19. Myocardial infarction and coronary deaths in the World Health Organization MONICA project: Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents
20. Invited commentary: Propensity scores
21. Variation in patient management and outcomes for acute coronary syndromes in Latin America and North America: Results from the Platelet IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) trial
22. Six-month outcome in unstable angina patients without previous myocardial infarction according to the use of tertiary cardiologic resources
23. Coronary angioplasty versus medical therapy for angina: The second Randomised Intervention Treatment of Angina (RITA-2) trial
24. Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study
25. Commparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review
26. Treatment and outcome of myocardial infarction in hospitals with and without invasive capability
27. The association between on-site cardiac catheterization facilities and the use of coronary angiography after acute myocardial infarction
28. Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction
29. Pravastatin reduces restenosis two years after percutaneous transluminal coronary angioplasty (REGRESS trial)
30. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; Final results of the fluvastatin angiographic restenosis (FLARE) trial